The recent conversations around a potential Canada–US pharmaceutical tariff have sparked understandable concern. Any time medications, supply chains, or international trade enter the news cycle, it is easy to worry about access, affordability, and continuity of care. Most people just want to know two simple things: Will my medicine still be at the pharmacy, and will it cost more?

As a pharmacist and pharmacy owner, I see what happens at the pharmacy counter every single day. Here is a simple, clear look at what these new rules really mean for all of us.

1. The impact won’t be immediate at the pharmacy counter
   Despite the headlines, patients should not expect sudden price increases at point of sale. Tariffs don’t translate directly into retail pricing overnight especially in pharmacy, where reimbursement structures, insurance contracts, and negotiated rates create a buffer between upstream changes and what patients pay.
   
   
2. If effects occur, they’ll be indirect and behind the scenes
   Where we may see shifts is in the operational backbone of pharmacy care:
   
   – Wholesaler acquisition costs.
   Tariffs could influence what wholesalers pay for certain products, which may eventually affect how pharmacies source inventory.
   
   – Inventory management & shortages
   If supply chains tighten, pharmacies may need to adjust ordering patterns or navigate temporary shortages.
   
   – Medication substitutions
   Patients may notice changes in the manufacturer or appearance of medications they’re used to. These substitutions are clinically relevant — even when the active ingredient is the same — and require pharmacist oversight to ensure safety and continuity.
   
   
3. What patients won’t see right now
   – Sudden price spikes at the register
   – Immediate loss of access to essential medications
   – Dramatic changes in pharmacy operations overnight
   
   The system simply doesn’t move that fast
   
   
4. What pharmacies could do right now
   Focus on preparation, communication, and continuity of care. That means:
   – Monitoring wholesaler updates and supply chain signals
   – Adjusting inventory strategies proactively
   – Educating patients about any medication changes
   – Coordinating with prescribers when substitutions are clinically necessary
   – Staying informed so we can respond not react
   
   Pharmacy is often the first place patients feel the ripple effects of policy changes. They will likely absorb as much of that turbulence as possible so patients experience stability.
   
   
5. Patience and understanding go a long way
   Much of what happens next depends on how the tariff is implemented, how manufacturers respond, and how wholesalers adjust. While the public may not see these moving parts, they shape the environment pharmacies and clinics operate in every day.
   

Our job at the front lines of care at this moment is to absorb the upstream turbulence so patients maintain stability in their care.

What concerns or challenges are you seeing at your pharmacy or clinic? Leave your thoughts and experiences in the comments below.

Until next time,

Dr. Freeman

——-

Sources & Further Reading

• Canada–U.S. tariff announcement and commencement
• U.S. pharmaceuticals tariff action
• U.S. tariff action affecting Canada
• FDA Drug Shortages Database

News Feature

• WXII News Report featuring Dr. Freeman